viernes, 28 de febrero de 2020

Coronavirus (COVID-19) Supply Chain Update | FDA

Coronavirus (COVID-19) Supply Chain Update | FDA



Coronavirus (COVID-19) Supply Chain Update

This statement is attributed to: FDA Commissioner Stephen M. Hahn, M.D.
As I have previously communicated, the FDA has been closely monitoring the supply chain with the expectation that the COVID-19 outbreak would likely impact the medical product supply chain, including potential disruptions to supply or shortages of critical medical products in the U.S.

A manufacturer has alerted us to a shortage of a human drug that was  recently added to the drug shortages list. The manufacturer just notified us that this shortage is related to a site affected by coronavirus. The shortage is due to an issue with manufacturing of an active pharmaceutical ingredient used in the drug.  It is important to note that there are other alternatives that can be used by patients. We are working with the manufacturer as well as other manufacturers to ...

No hay comentarios: